Evidence map›Paper›PMID 20375494›Full record

SynthesisAmerican journal of nephrology2010

Prevention and treatment of acute kidney injury in patients undergoing cardiac surgery: a systematic review.

Meyeon Park, Steven G Coca, Sagar U Nigwekar, Amit X Garg, Susan Garwood, Chirag R Parikh

Open access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in American journal of nephrology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 68 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Mesenchymal Stromal Cells for AKI after Cardiac Surgery.Journal of the American Society of Nephrology : JASN · 2018
    Article
  13. Article
  14. Article
  15. Prevention and Treatment of Cardiac Surgery Associated Acute Kidney Injury.Journal of anesthesia and perioperative medicine · 2016
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Meyeon ParkClinical Epidemiology Research Center, Veterans Affairs Medical Center, West Haven, Conn. 06516, USA.
Steven G Coca
Sagar U Nigwekar
Amit X Garg
Susan Garwood
Chirag R Parikh
Yale University · USPediatric Nephrology of Alabama · USUniversity of Rochester · USVeterans Health Administration · US

Funding

Novel Biomarkers in Cardiac Surgery to Detect Acute Kidney InjuryR01HL085757 · NHLBI · YALE UNIVERSITY · PI PARIKH, CHIRAG R · 2007 to 2019
$10.3M
NHLBI NIH HHS HL-085757NHLBI NIH HHS R01 HL085757
6 · The paper itself

Abstract

backgroundAcute kidney injury (AKI) is common in patients undergoing cardiac surgery and is associated with a high rate of death, long-term sequelae and healthcare costs. We conducted a systematic review of randomized controlled trials for strategies to prevent or treat AKI in cardiac surgery.

methodsWe screened Medline, Scopus, Cochrane Renal Library, and Google Scholar for randomized controlled trails in cardiac surgery for prevention or treatment of AKI in adults.

resultsWe identified 70 studies that contained a total of 5,554 participants published until November 2008. Most studies were small in sample size, were single-center, focused on preventive strategies, and displayed wide variation in AKI definitions. Only 26% were assessed to be of high quality according to the Jadad criteria. The types of strategies with possible protective efficacy were dopaminergic agents, vasodilators, anti-inflammatory agents, and pump/perfusion strategies. When analyzed separately, dopamine and N-acetylcysteine did not reduce the risk for AKI.

conclusionsThis summary of all the literature on prevention and treatment strategies for AKI in cardiac surgery highlights the need for better information. The results advocate large, good-quality, multicenter studies to determine whether promising interventions reliably reduce rates of acute renal replacement therapy and mortality in the cardiac surgery setting.

Indexed as

Thoracic SurgeryAcute Kidney InjuryAgedDopamine AgentsFemaleHeart DiseasesHumansInflammationKidneyMaleMiddle AgedRandomized Controlled Trials as TopicRenal Replacement TherapyRisk FactorsTreatment OutcomeVasodilator AgentsDopamine AgentsVasodilator Agents

Identifiers

PMID20375494
PMCPMC2883845
OpenAlexW2092469179

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.